Total paracentesis has also been shown to be as safe as repeated partial paracentesis and to shorten the period of hospitalization -- and may even be performed on an outpatient basis. [34] However ...

In this context, the results of the study by Angeli et al. 1 suggest that treatment of ascites in patients with cirrhosis should be initiated with a combination of either spironolactone 2,3,4,5 or ...

Liver cirrhosis is a serious condition in which healthy liver tissue is replaced by scar tissue, severely affecting the liver ...

Ascites can develop in patients with cirrhosis as a result of disturbed fluid and electrolyte balance. Not all patients with ascites respond to spironolactone, which is the standard treatment for ...

The most common symptom of ascites is abnormal swelling of the abdomen due to excessive fluid build-up or retention. Other ...

The patent supports BioVie’s liquid formulation of terlipressin for development of a more patient-centric ambulatory treatment regimen for patients with ascites and hepatic failure in the US. Patients ...

Causes Cirrhotic ascites develop when blood pressure in the portal vein — the blood vessel that carries blood from the ...

Swelling in the feet can often be overlooked as just a sign of a long day on your feet, but persistent or unexplained ...

白蛋白是血浆中最丰富的蛋白质，由肝脏合成。基于其胶体和非胶体特性，人血白蛋白不仅可改善低血容量，还能通过结合内源性和外源性化合物、发挥抗氧化作用、调节炎症和免疫反应、改善心脏功能及恢复内皮完整性等多种病理生理机制作用于失代偿期肝硬化[1]。因此，从病 ...

The study is to assess the safety and efficacy of Intravenous OCE-205 in adults diagnosed with cirrhosis with ascites who have developed hepatorenal syndrome-acute kidney injury (HRS-AKI). (Funding ...

Nonurinary sodium excretion in afebrile cirrhotic patients without diarrhea is approximately 10 mmol/day. [13] Patients with ascites on no diuretics commonly have renal sodium excretion of < 20 ...

Patents covering BioVie’s terlipressin liquid formulation now secured in the United States, India and Chile, and are pending in nine additional ...